Figures & data
Table 1 The Most Frequent Cardiac Complications Related to 5-FU AdministrationCitation2
Figure 1 Mechanisms of cardiac toxicities associated with 5-FU/capecitabine Adapted from Shiga, T, Hiraide, M Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines. Curr. Treat. Options in Oncol. 2020;21(27). This article is licensed under a Creative Commons Attribution 4.0 International License, http://creativecommons.org/licenses/by/4.0/ .Citation6
![Figure 1 Mechanisms of cardiac toxicities associated with 5-FU/capecitabine Adapted from Shiga, T, Hiraide, M Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines. Curr. Treat. Options in Oncol. 2020;21(27). This article is licensed under a Creative Commons Attribution 4.0 International License, http://creativecommons.org/licenses/by/4.0/ .Citation6](/cms/asset/287a7fa3-b089-4fcd-bb90-d3cd03659910/dott_a_12175433_f0001_c.jpg)
Table 3 Switch to a Different Fluoropyrimidine
Table 4 Summary of Few Cases Rechallenged with Bolus5-FU
Table 5 Non-Fluoropyrimidine Containing Chemotherapy Regimen
Table 6 Suggested Recommendations